Narrated podcasts

#Biotechnology #Drug development #Drug discovery #Health #Life sciences #Narrated podcasts #Pharmaceutical

2030 Life Sciences and Health in the Digital Age (Part 1)

This article is the first in a two-part series based on The Pistoia Alliance report. Written in retrospect from the world as it is in 2030, it looks at how healthcare has changed in the intervening decade, covering the socio-economic and political evolutions that have happened, the subsequent effects on… Read More

#Podcasts

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical #Research

Evolution of User Experience for life sciences

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to… Read More

#Podcasts

#Biotechnology #Drug development #Drug discovery #Narrated podcasts #Pharmaceutical

Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic

Non-alcoholic fatty liver disease (NAFLD) has quietly become one of the most common causes of chronic liver disease in the modern world. If this prevalence is allowed to continue the economic and clinical burden will reach a staggering level. Non-alcoholic fatty liver disease (NAFLD) consists of a complex combination of… Read More

#Podcasts

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical

Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency

This article will describe, with examples, how understanding the likely mechanisms of false positives in advance of screening informs the design of the hit triage, thus increasing the likelihood of discovering optimisable chemical matter and avoiding costly wasting of resource. We describe the use of a bespoke ‘Robustness Set’ of… Read More

#Podcasts

#Academic #AI / data analytics / healthtech / informatics #Analysis #Cellular & Molecular biology #Chemistry #Clinical trials #Drug development #Drug discovery #Narrated podcasts

The COVID-19 Race: how mouse models will help researchers cross the finish line

The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe. Amid the worldwide health emergency created by high infection rates, rapid transmission spread and relatively high mortality rates, researchers are under pressure to understand the disease’s pathogenesis, develop… Read More

#Podcasts

#Narrated podcasts

Cryo-EM accelerates drug discovery by delivering previously intractable structural insights

Cryo-electron microscopy (cryo-EM), a powerful biophysical technique that can analyse molecular assemblies, is changing the paradigm in structure-based drug design. As targets become more challenging, solving structures of drug target molecules or biologics becomes increasingly difficult. Cryo-EM empowers drug discovery teams to take advantage of rational drug design for many… Read More

#Podcasts

#Narrated podcasts

Creating Vaccines, drop by drop

The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new. Microfluidics technologies can be used to accelerate the vaccine development process in a number of ways, not least in the directed evolution of… Read More

#Podcasts

#Narrated podcasts

The Reality of Virtual Pharmaceutical Companies

In this episode, we discuss the oxymoronic proposition of a Virtual Pharmaceutical Company (VPC) and the typical adopted business model, as well as provide examples of such companies currently trying to undertake this adventurous task. The vagaries and complexities of bringing a therapeutic drug to market through the Drug Discovery… Read More

#Podcasts

#Narrated podcasts

Race To COVID-19 Cure – The Core Model for solving the pandemic crisis (Part 2)

Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This two part article series examines the major initiatives being explored at the public policy level to contain the spread… Read More

#Podcasts

#Narrated podcasts

Race To COVID-19 Cure – The Core Model for solving the pandemic crisis (Part 1)

Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This 2 part episode series examines the major initiatives being explored at the public policy level to contain the spread… Read More

#Podcasts

#Narrated podcasts

The COVID-19 antiviral race: we’re all in this together

In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically effective antiviral. The aptly named COVID-19 Moonshot aims to accomplish this task more… Read More

#Podcasts

#Narrated podcasts

Using Live-Cell Imaging Systems to Transform Perspectives in Drug Discovery

Live-cell imaging has transformed the study of cell behaviour and function. The technique allows researchers to monitor internal cell structures, interactions and processes in real-time, and over time. In drug discovery, understanding the dynamic processes of cells provides an enhanced picture of drug pharmacology, enabling more reliable predictions of clinical… Read More

#Podcasts

#Narrated podcasts

Fail Early, Fail Fast – A phenotypic rescue approach

New disease targets frequently emerge in literature, but the thorough target validation required to consider these targets for a drug discovery programme is often lacking. In pharmacological or genetic perturbation studies using complex biological assays, undesired off-target effects cannot be easily distinguished from the intended mode of action at the… Read More

#Podcasts

#Narrated podcasts

Unlocking Clinical Trial Data to Uncover New Therapeutic Opportunities

This article discusses opportunities, challenges and best practices in leveraging infrastructure excellence and AI to unlock the value of early or inconclusive clinical trial data. The goal… driving stronger biomarker-based insights and decisions and helping to advance new cures and treatment approaches. As we all know, data is increasingly king… Read More

#Podcasts